Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1996 Nov;103(11):1156-8.
doi: 10.1111/j.1471-0528.1996.tb09600.x.

Recurrent stage IB cervical carcinoma: evaluation of the effectiveness of routine follow up surveillance

A Ansink  1 , A de Barros Lopes, R Naik, J M Monaghan
Affiliations

Recurrent stage IB cervical carcinoma: evaluation of the effectiveness of routine follow up surveillance

A Ansink et al. Br J Obstet Gynaecol. 1996 Nov.

Abstract

Objective: To study the effectiveness of follow up surveillance in detecting recurrent disease following radical hysterectomy for Stage IB cervical carcinoma.

Design: Retrospective analysis of clinical records using a computerised database.

Participants: Six hundred and seventy-four patients with Stage IB carcinoma of the cervix underwent radical hysterectomy and lymph node dissection.

Interventions: Standard follow up surveillance consisted of clinical history and physical examination six weeks post surgery, and subsequently three monthly for the first year, six monthly for the second year, and yearly thereafter until 10 years post-treatment.

Results: Of the 674 patients, 112 (17%) developed recurrent disease. In only 29/112 (26%) was recurrent disease detected at the time of routine follow up visits. Nearly half of the patients (44%) were referred by their general practitioner between visits to the clinic because of suspicion of recurrent disease.

Conclusion: Routine follow up surveillance is ineffective in detecting recurrent cervical carcinoma. Only one in four recurrences were detected at the time of a clinical visit.

PubMed Disclaimer

Comment in